Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Applying a microfluidic device to improve the Ca2+ separation performance of the liquid-liquid extraction process.
Sci Rep. 2022 Dec 20;12(1):21984. doi: 10.1038/s41598-022-26529-9.
Sci Rep. 2022.
PMID: 36539438
Free PMC article.
Wavelet-artificial neural network to predict the acetone sensing by indium oxide/iron oxide nanocomposites.
Iranmanesh R, Pourahmad A, Shabestani DS, Jazayeri SS, Sadeqi H, Akhavan J, Tounsi A.
Iranmanesh R, et al. Among authors: jazayeri ss.
Sci Rep. 2023 Mar 14;13(1):4266. doi: 10.1038/s41598-023-29898-x.
Sci Rep. 2023.
PMID: 36918606
Free PMC article.
Item in Clipboard
Author Correction: Wavelet-artificial neural network to predict the acetone sensing by indium oxide/iron oxide nanocomposites.
Iranmanesh R, Pourahmad A, Shabestani DS, Jazayeri SS, Sadeqi H, Akhavan J, Tounsi A.
Iranmanesh R, et al. Among authors: jazayeri ss.
Sci Rep. 2023 Nov 7;13(1):19271. doi: 10.1038/s41598-023-46411-6.
Sci Rep. 2023.
PMID: 37935799
Free PMC article.
No abstract available.
Item in Clipboard
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Blauvelt A, Kempers S, Lain E, Schlesinger T, Tyring S, Forman S, Ablon G, Martin G, Wang H, Cutler DL, Fang J, Kwan MR; Phase 3 Tirbanibulin for Actinic Keratosis Group.
Blauvelt A, et al.
N Engl J Med. 2021 Feb 11;384(6):512-520. doi: 10.1056/NEJMoa2024040.
N Engl J Med. 2021.
PMID: 33567191
Clinical Trial.
Item in Clipboard
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group.
Blauvelt A, et al.
Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15.
Br J Dermatol. 2020.
PMID: 31887225
Free PMC article.
Clinical Trial.
Item in Clipboard
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators.
Simpson EL, et al.
N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30.
N Engl J Med. 2016.
PMID: 27690741
Free article.
Clinical Trial.
Item in Clipboard
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators.
Griffiths CE, et al.
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
Lancet. 2015.
PMID: 26072109
Clinical Trial.
Item in Clipboard
Cite
Cite